A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric Kit and Instructions for Use

BACKGROUND: Limited data exist regarding how medications for pediatric use can be developed to minimize medication errors. The integrase inhibitor raltegravir was developed for use in neonates (≥2 kg). Anticipating that neonatal administration would be performed primarily by mothers with varying deg...

Descripción completa

Detalles Bibliográficos
Autores principales: Mills, Alexander, Myers, Laurie, Raudenbush, Casey, Vossen, David A., Teppler, Hedy, Miteva, Yanna R., Seeley, Suzanne, Homony, Brenda, Straus, Walter L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
HIV Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658952/
https://www.ncbi.nlm.nih.gov/pubmed/34694252
http://dx.doi.org/10.1097/INF.0000000000003334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658952/
https://www.ncbi.nlm.nih.gov/pubmed/34694252
http://dx.doi.org/10.1097/INF.0000000000003334

Ejemplares similares